Delivery Order SPE2DB22D1106-SPE2DB25FEMP3
Award Date
5/8/25
Potential Completion Date
5/9/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,310.30 delivery order contract is for the provision of ZORYVE 0.3% FOAM 60GM, a medical product, with a performance period through April 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,120.26 firm-fixed-price delivery order is for the supply of ZORYVE 0.3% Foam, a medical product, with a period of performance through October 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,208.58 firm fixed price delivery order is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of June 26, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,562.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, to...
This federal contract award, valued at $2,281.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORYVE 0.3% FOAM 60GM, a medical product, with a completion date of June 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,574.00, is for the provision of ZORYVE 0.3% FOAM 60GM, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 12, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,800.64, is for the supply of ZORYVE 0.3% FOAM 60GM medical products. The contract is a Firm Fixed Price agreement with an ultimate completion date of November 7, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award is for the delivery of ZORYVE 0.3% foam, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,317.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of November 6, 2024. The award was not designated with a set-aside requirement, indicating open competition....
This federal contract award, valued at $2,988.77, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORYVE 0.3% FOAM 60GM, a topical medication, and does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
This federal contract award, with an identifier of SPE2DX15D3012|SPE2DX25F8HZ7, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,609.55, is a delivery order for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as the...